Bristol-Myers Squibb Company (BMY)
-NYSE 47.40 
0.40(0.85%) 25 May 04:00 SGT|After Hours
:
47.43 0.03 (0.06%) 25 May 06:22 SGT
| Prev Close: | 47.00 |
|---|
| Open: | 46.56 |
|---|
| Bid: | 47.48 x 400 |
|---|
| Ask: | 47.59 x 200 |
|---|
| 1y Target Est: | 40.77 |
|---|
| Beta: | 0.12 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 45.81 - 47.55 |
|---|
| 52wk Range: | 30.64 - 47.55 |
|---|
| Volume: | 12,605,344 |
|---|
| Avg Vol (3m): | 10,455,600 |
|---|
| Market Cap: | 77.86B |
|---|
| P/E (ttm): | 53.68 |
|---|
| EPS (ttm): | 0.88 |
|---|
| Div & Yield: | 1.40 (3.20%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Final Glance: Pharmaceuticals companiesAP(Sat, 06:03 SGT)
- Midday Glance: Pharmaceuticals companiesAP(Sat, 01:17 SGT)
- Early Glance: Pharmaceuticals companiesAP(Fri, 24 May)
- Alkermes posts 4Q profit as royalty payments riseAP(Fri, 24 May)
- Ahead of the Bell: Analyst upgrades Bristol-MyersAP(Wed, 22 May)
- FDA OKs Bristol's HIV drug for younger patientsAP(Sat, 4 May)
- Sanofi earnings slashed in first quarterAP(Thu, 2 May)
- Earnings Preview: Merck to key on coming new drugsAP(Tue, 30 Apr)
- Earnings Preview: Pfizer to report Q1 resultsAP(Sat, 27 Apr)
- Bristol net plunges 45 pct. on generic competitionAP(Thu, 25 Apr)
- Bristol-Myers Inks OTC DealZacks(Thu, 14 Feb)
- MDCO-BMY Deal Comes into EffectZacks(Tue, 12 Feb)
- Vical's Loss Narrower than ExpectedZacks(Sat, 9 Feb)
- Generics Continue to Hurt SanofiZacks(Sat, 9 Feb)
- Pipeline Setback for IdenixZacks(Fri, 8 Feb)
Key Statistics
| Forward P/E (1 yr): | 22.15 |
|---|
| P/S (ttm): | 4.77 |
|---|
| Ex-Dividend Date: | 03-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.81 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.44 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 2.73 |
|---|
Business Summary
Bristol-Myers Squibb Company, a biopharmaceutical company, discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide.
View More